Safety outcomes of anti-platelet therapy post coronary artery bypass graft surgery: A systematic review and network meta-analysis of randomized control trials
CONCLUSION: No significant difference was found between monotherapy or dual-antiplatelet therapy for the major bleeding risk safety outcome, however DAPT was found to have a significantly higher rate of minor bleeding complications post-CABG. DAPT should be considered as the antiplatelet modality of choice post-CABG.PMID:36803180 | DOI:10.1177/02676591231159513
Source: Perfusion - Category: Cardiovascular & Thoracic Surgery Authors: Syed U Hasan Alina Pervez Arshad A Shah Syed DA Shah Muhammad Aslam Anosha Arshad Amna S Rajput M Mujeeb Zubair Source Type: research
More News: Aspirin | Bleeding | Cardiovascular & Thoracic Surgery | Clopidogrel | Coronary Artery Bypass Graft | Heart Attack | Perfusion | Plavix | Statistics | Stroke